APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor (VEGF) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Growth and Trends Forecast to 2032

22 December 202587 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor (VEGF) Inhibitors Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vascular Endothelial Growth Factor (VEGF) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Vascular Endothelial Growth Factor (VEGF) Inhibitors market include Sanofi., Novartis AG, Bayer AG, Regeneron Pharmaceuticals Inc. and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vascular Endothelial Growth Factor (VEGF) Inhibitors market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vascular Endothelial Growth Factor (VEGF) Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Company

Sanofi.

Novartis AG

Bayer AG

Regeneron Pharmaceuticals Inc.

F. Hoffmann-La Roche Ltd.

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Type

VEGF-D Inhibitor

VEGF-C Inhibitor

VEGF-B Inhibitor

VEGF-A Inhibitor

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Application

Oncology

Ophthalmology

Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor (VEGF) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor (VEGF) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Vascular Endothelial Growth Factor (VEGF) Inhibitors companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2021-2026) Table 4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2027-2032) Table 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2026) Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share Forecasted by Type (2027-2032) Table 11. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2026) Table 24. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share Forecasted by Application (2027-2032) Table 26. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Trends Table 37. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Drivers Table 38. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Opportunities and Challenges Table 39. Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Restraints Table 40. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Company (2021-2026) Table 42. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Company Headquarters & Area Served Table 44. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company, Product Type & Application Table 45. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi. Company Information Table 49. Sanofi. Business Overview Table 50. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 52. Sanofi. Recent Development Table 53. Novartis AG Company Information Table 54. Novartis AG Business Overview Table 55. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 57. Novartis AG Recent Development Table 58. Bayer AG Company Information Table 59. Bayer AG Business Overview Table 60. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 62. Bayer AG Recent Development Table 63. Regeneron Pharmaceuticals Inc. Company Information Table 64. Regeneron Pharmaceuticals Inc. Business Overview Table 65. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 67. Regeneron Pharmaceuticals Inc. Recent Development Table 68. F. Hoffmann-La Roche Ltd. Company Information Table 69. F. Hoffmann-La Roche Ltd. Business Overview Table 70. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio Table 72. F. Hoffmann-La Roche Ltd. Recent Development Table 73. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 74. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 75. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2026) Table 76. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 77. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Country (2027-2032) Table 78. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 80. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2026) Table 81. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Country (2027-2032) Table 83. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 85. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2026) Table 86. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Country (2027-2032) Table 88. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 90. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2026) Table 91. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Country (2027-2032) Table 93. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 95. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2026) Table 96. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Forecast by Country (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Image Figure 3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region: 2025 VS 2032 Figure 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2021-2032) Figure 7. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. VEGF-D Inhibitor Image Figure 13. Global VEGF-D Inhibitor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. VEGF-C Inhibitor Image Figure 15. Global VEGF-C Inhibitor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. VEGF-B Inhibitor Image Figure 17. Global VEGF-B Inhibitor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. VEGF-A Inhibitor Image Figure 19. Global VEGF-A Inhibitor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2025 VS 2032 Figure 22. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2032) Figure 23. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2032) Figure 25. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2021-2032) Figure 27. Oncology Image Figure 28. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Ophthalmology Image Figure 30. Global Ophthalmology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2025 VS 2032 Figure 33. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2032) Figure 34. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2032) Figure 36. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 43. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 46. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 49. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 52. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • VEGF-D Inhibitor
  • VEGF-C Inhibitor
  • VEGF-B Inhibitor
  • VEGF-A Inhibitor
Applications
  • Oncology
  • Ophthalmology
Companies covered
  • Sanofi.
  • Novartis AG
  • Bayer AG
  • Regeneron Pharmaceuticals Inc.
  • F. Hoffmann-La Roche Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2021-2032)
  5. 1.4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2021-2026)
  6. 1.4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2027-2032)
  7. 1.5 Key Regions Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2021-2032)
  8. 1.5.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2021-2032)
2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 VEGF-D Inhibitor
  3. 2.1.2 VEGF-C Inhibitor
  4. 2.1.3 VEGF-B Inhibitor
  5. 2.1.4 VEGF-A Inhibitor
  6. 2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  7. 2.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions
  11. 2.3.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Type (2021-2026)
3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Oncology
  3. 3.1.2 Ophthalmology
  4. 3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  5. 3.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions
  9. 3.3.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Trends
  2. 4.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Drivers
  3. 4.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Opportunities and Challenges
  4. 4.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2021-2026)
  2. 5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Company Headquarters & Area Served
  4. 5.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company, Product Type & Application
  5. 5.5 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Vascular Endothelial Growth Factor (VEGF) Inhibitors Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi.
  2. 6.1.1 Sanofi. Company Information
  3. 6.1.2 Sanofi. Business Overview
  4. 6.1.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  6. 6.1.5 Sanofi. Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 Regeneron Pharmaceuticals Inc.
  20. 6.4.1 Regeneron Pharmaceuticals Inc. Company Information
  21. 6.4.2 Regeneron Pharmaceuticals Inc. Business Overview
  22. 6.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  24. 6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
  25. 6.5 F. Hoffmann-La Roche Ltd.
  26. 6.5.1 F. Hoffmann-La Roche Ltd. Company Information
  27. 6.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
7 North America
  1. 7.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  3. 7.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  3. 8.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  3. 10.3 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst